Epidemiological Evaluation of Rubella Virus Infection among Pregnant Women in Ibadan, Nigeria

Journal of Immunoassay & Immunochemistry
Olubusuyi M AdewumiOlubukola Adesina

Abstract

Rubella is a vaccine-preventable, mild rash-inducing viral disease with complications that include a spectrum of birth defects in the developing fetus, especially if the infection is acquired in the early months of pregnancy. Consequently, the primary objective of global rubella control programs is prevention of congenital rubella infection and associated birth defects. Despite the availability of safe and effective vaccines, and the elimination of the rubella virus in many developed countries, substantial commitment to rubella control has not been demonstrated in developing countries. This study appraises immunity to rubella, and consequently makes appropriate recommendations aimed at facilitating effective control. A cross-sectional sero-surveillance study was carried out among defined 272 consenting ante-natal clinic attendees in south-western, Nigeria. Prevalence rates of 91.54% and 1.84% were recorded for the anti-rubella virus (anti-RV) IgG and IgM, respectively. Also, 90.7% and 92.3% of the women aged ≤30 years and >30 years, respectively, had detectable anti-RV IgG. No significant association (p = 0.94) was recorded between anti-RV IgG detection and age of the women. Previous exposure and susceptibility of significant f...Continue Reading

References

Jan 1, 1977·Transactions of the Royal Society of Tropical Medicine and Hygiene·H A OdelolaJ B Familusi
Oct 23, 1965·Lancet·H P LambertA J Wellsteed
Jan 1, 1974·Archives of Disease in Childhood·A U Antia
Mar 1, 1980·International Journal of Epidemiology·E G Knox
Feb 8, 2000·International Journal of Epidemiology·F T Cutts, E Vynnycky
Oct 12, 2000·Clinical Microbiology Reviews·J Y Lee, D S Bowden
Jul 20, 2004·Birth Defects Research. Part A, Clinical and Molecular Teratology·C D AtreyaS Kulkarni
Jun 16, 2006·Epidemiologic Reviews·Joan L RobinsonGraham A Tipples
Jun 17, 2011·The Journal of Infectious Diseases·James L GoodsonSusan Reef
Jun 17, 2011·The Journal of Infectious Diseases·S E ReefS Cochi
Aug 30, 2013·Expert Review of Vaccines·Felicity T CuttsCharlotte J E Metcalf

❮ Previous
Next ❯

Citations

Mar 21, 2020·Human Vaccines & Immunotherapeutics·Zemenu Yohannes KassaSolomon Asnake

❮ Previous
Next ❯

Software Mentioned

Statistical Package for the Social Sciences ( SPSS )

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Related Papers

Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
E PandolfiA E Tozzi
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
H SoleimanjahiS Faghihzadeh
© 2021 Meta ULC. All rights reserved